Drug Approvals
🇺🇸 FDA Page 43FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global drug approvals & regulatory decisions. Gain critical intelligence on new therapies, market access, and competitive landscapes for pharma BD.
Showing 505–516 of 665 articles
Moderna FDA Talks Focus on Phase 4 COVID Vaccine Data
Mounjaro FDA Approval Obesity: Eli Lilly's Tirzepatide Awaits
Osimertinib FDA Approval Expands Early-Stage NSCLC Treatment
Contineum Therapeutics PIPE-791 Shows Positive Phase 1b Results for Chronic Osteoarthritis Pain
Aquestive Therapeutics Faces Securities Fraud Lawsuit Despite Anaphylm FDA Review Progress
Eli Lilly's Foundayo (Orforglipron) Receives FDA Approval for Obesity Treatment as Company Reports Strong Q1 2026 Results
FDA Approval OncoBlast: Market Impact for Advanced Melanoma
Perimeter Medical's Claire OCT+AI Receives FDA Approval for Breast Cancer Surgery Margin Assessment
Regeneron Q1 2026 Earnings: Dupixent Sales Surge 33% to $4.9B, EYLEA HD Shows Strong Growth
CAR-T Therapy Clinical Trials: Insights from ASCO 2026 and FDA Approval Implications
IEEE CoG 2026: Industry Day and Game Dev Tutorials Recap
FDA Grants Priority Review for Gilead's Bictegravir Plus Lenacapavir HIV Treatment Combination